Bayesian precision dosing software system that calculates precise dosing regimens in order to predict serum levels and toxicity probability functions

Active Purchase Order Awarded Last action

Contract number
HT001425PE007
Awardee
Awarding agency
Obligated
$41,480

Award facts

Contract value 40% obligated
  • $41,480.00 Current, with exercised options
  • $103,700.00 Potential, with all options
Completion date 24% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Total Small Business
Competition
Competed under SAP · 4 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00001 $20,740
Original award $20,740

About this award

The Defense Health Agency issued a purchase order to Insight RX, Inc. on August 1, 2025, for a Bayesian precision dosing software system valued at $103,700.00. The order is set aside for total small business and carries firm fixed price terms. The software calculates precise dosing regimens to predict serum levels and toxicity probability functions. Place of performance is Bethesda, Maryland. The order runs through July 31, 2030.

Quick answers

Who was awarded contract HT001425PE007?

HT001425PE007 was awarded to Insight RX, Inc. by Defense Health Agency (Department of Defense) on August 1, 2025.

How much is contract HT001425PE007 worth?

The government has obligated $41,480 on HT001425PE007. Its potential value, with all options, is $103,700.

Was contract HT001425PE007 competed?

The extent of competition for HT001425PE007 was competed under sap. The government received 4 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award